Xceleron Inc. — Investor Relations & Filings

Xceleron Inc. is a specialist provider of ultra-sensitive bioanalytical services crucial for accelerating early drug development. The company pioneered the application of Accelerator Mass Spectrometry (AMS) technology in life sciences, specifically for novel clinical designs, including human microdose and microtracer studies. Xceleron utilizes its expertise to investigate the pharmacokinetics and metabolism of developmental drugs. Key services include micro-dosing, pre-clinical evaluation, intravenous pharmacokinetics, metabolite profiling, and mass balance investigations in humans, enabling predictive clinical research and supporting smarter drug development decisions.